Chinese Academy of Sciences

A virus treatment for glioblastoma, tested in eight patients, showed safety and efficacy below a maximum dose, with complete remission in one patient, leading to phase II trials. The treatment, Ad-TD-nsIL12, uses a genetically engineered adenovirus to deliver a modified IL-12, enhancing immune response without toxicity.

New study in *Nature* unveils artificial receptors targeting coronaviruses via modular design, potentially revolutionizing antiviral drug development.

Multinational pharma companies to showcase latest innovations at CIIE, including Teva's Austedo XR and Regro, Fosun Pharma's non-invasive device for tremor, and Gilead Sciences' Seladelpar for PBC.

Wu Weihua calls for global collaboration in life sciences at the 2024 World Life Sciences Conference in Hainan. George Fitzgerald Smoot III discusses integrating physics into healthcare, including AI and space-based medical innovations. Randy W. Schekman emphasizes the importance of fundamental research in addressing global health challenges. Luo Qingming highlights Hainan University's role in the conference, aiming to advance life sciences through academic exchanges.

Radiomics in CRC precision medicine: 2013-2023 bibliometric analysis shows China leads in publication volume, U.S. in citations. Key themes include deep learning, texture analysis, and AI integration for improved CRC management.

CAS Space launched its fourth Kinetica-1 solid rocket, sending five satellites into orbit from Jiuquan Satellite Launch Center. The payload included two radar imaging satellites, an X-band radar satellite, and two meteorology satellites with GNSS payloads. This was the second Kinetica-1 launch of 2024 and part of China's 45th launch this year, which includes contributions from commercial companies like CAS Space.

Metformin, a diabetes medication, shows potential to slow ageing in monkeys by preserving cognitive function and delaying ageing effects in various tissues, particularly the brain. The study suggests metformin could be used to delay ageing in humans, with further research planned.

Metformin, a diabetes drug used since the 1950s, has been found to de-age monkeys, potentially reversing aging in humans. The drug slowed aging in monkeys, improving cognition and rejuvenating tissues and organs, suggesting it could delay aging-associated brain deterioration.

Chen Kaixian, CAS academician, spoke at UM on multidisciplinary research promoting TCM's heritage and innovative development, detailing TCM formulae, meridians, acupuncture, and new drug research. His work in drug design and TCM modernisation was highlighted, emphasizing TCM's relevance to contemporary health issues and the potential of integrating TCM with Western medicine.